Objective
Seeks long-term capital appreciation.
Overview
A highly diversified international equity fund with a focus on value companies of high quality.
The portfolio managers are supported by the full resources of Schroders.
Performance
Performance data quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted.
SI = Since Inception.
Fund Inception: 08/30/2006
Share Class Inception: 12/30/14.
Class SDR-shares performance from 12/30/14 through 10/21/16 reflects the performance, fees, and expenses of R6 Class of the predecessor fund Schroder International Multi-Cap Value Fund (the "Predecessor Fund") and, prior to 12/30/14, the performance, fees, and expenses of the Predecessor Fund's Investor Class. If Class SDR fees and expenses were reflected, performance would have differed. SI performance is calculated from 8/30/06.
Characteristics
# of Holdings | 596 |
Turnover- (6/30/2022) | 97% |
Active Share | 83% |
FUND | MSCI ACWI ex USA Index | |
---|---|---|
Price/Earnings | 8.2x | 11.4x |
Price/Book | 1.2x | 1.6x |
Asset Weighted Market Cap (billions) | $53.2 | $80.8 |
Median Market Cap (billions) | $7.9 | $8.5 |
Return on Equity | 13.3% | 13.9% |
Roche Holding AG | 1.36 |
Novartis AG | 1.34 |
KDDI Corp. | 1.31 |
AstraZeneca plc | 1.28 |
GlaxoSmithKline plc | 1.28 |
Equinor ASA | 1.27 |
Astellas Pharma, Inc. | 1.26 |
Shell plc | 1.26 |
Sanofi | 1.23 |
Swisscom AG | 1.22 |
Total Portfolio % | 12.81 |
Less than $1 billion | 3 | |
$1 billion - $5 billion | 16 | |
$5 billion - $20 billion | 32 | |
Greater than $20 billion | 48 | |
Not Classified | 0 |
Alpha (5 Year)
|
-0.81 |
Down Capture (5 Year)
|
105.40 |
Information Ratio (5 Year)
|
-0.21 |
Sharpe Ratio (5 Year)
|
0.11 |
Up Capture (5 Year)
|
100.79 |
FUND |
BENCHMARK | UNDERWEIGHT / OVERWEIGHT | |||||
---|---|---|---|---|---|---|---|
3/31/22 | 6/30/22 | 6/30/22 | -6 0 6 | ||||
Communication Services | 8 | 13 | 7 | ||||
Energy | 12 | 10 | 6 | ||||
Materials | 12 | 10 | 8 | ||||
Financials | 18 | 21 | 20 | ||||
Health Care | 11 | 11 | 10 | ||||
Information Technology | 13 | 11 | 11 | ||||
Utilities | 3 | 3 | 3 | ||||
Real Estate | 1 | 2 | 2 | ||||
Consumer Discretionary | 9 | 9 | 12 | ||||
Industrials | 9 | 8 | 12 | ||||
Consumer Staples | 4 | 3 | 9 |
Distribution Date | Distribution NAV | ordinary income | short term capital gains | long term capital gains | total distribution |
---|---|---|---|---|---|
6/29/2022 | 9.00 | $0.0980 | $0.0000 | $0.0000 | $0.0980 |
3/30/2022 | 10.21 | $0.0495 | $0.0000 | $0.0000 | $0.0495 |
12/30/2021 | 10.26 | $0.1184 | $0.0000 | $0.0000 | $0.1184 |
12/13/2021 | 10.21 | $0.0000 | $0.0000 | $0.0000 | $0.0000 |
9/29/2021 | 10.11 | $0.0635 | $0.0000 | $0.0000 | $0.0635 |
Insights
Fund Literature